Novovax Covid-19 vaccine gets emergency use nod for those aged between 12-18 years in India

According to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of India (SII) under the brand name Covovax and is the first protein-based vaccine authorized for use in this age group in India.

from Zee News :India National https://ift.tt/cK3F58o